Lanthanum in Dialysis, the LANDMARK Trial: A #NephJC Editorial

This publication has 11 references indexed in Scilit:

• Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis
  JAMA, 2021
• Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality
  Renal Replacement Therapy, 2020
• Cardiovascular Outcomes of Calcium-Free vs Calcium-Based Phosphate Binders in Patients 65 Years or Older With End-stage Renal Disease Requiring Hemodialysis
  JAMA Internal Medicine, 2019
• Phosphate-Binder Use in US Dialysis Patients: Prevalence, Costs, Evidence, and Policies
  American Journal of Kidney Diseases, 2018
• Deleterious effects of phosphate on vascular and endothelial function via disruption to the nitric oxide pathway
  Nephrology Dialysis Transplantation, 2016
• Assessing the Health Impact of Phosphorus in the Food Supply: Issues and Considerations
  Advances in Nutrition, 2014
• Calcium-based phosphate binders and chronic kidney disease
  The Lancet, 2014
• Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder
  Therapeutic Apheresis and Dialysis, 2013
• Pill Burden, Adherence, Hyperphosphatemia, and Quality of Life in Maintenance Dialysis Patients
  Clinical Journal of the American Society of Nephrology, 2009
• Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients
  Kidney International, 2007